The highly anticipated financial results for the third quarter of Ekso Bionics Holdings (NASDAQ: EKSO) are scheduled to be disclosed on Monday 28th October 2024. This important update will be made available after market close, providing investors and market participants with key information regarding the company's financial status.
Wall Street financial experts are forecasting that the business will announce an expected $0.10 loss per share for the quarter. Moreover, the firm is anticipated to disclose a total revenue of $5.55 million for this specific period.
Wall street analysts expect the company to generate a total revenue of $20.31 million for the entire year. Additionally, these analysts also foresee the company achieving an estimated loss of $0.49 per share for the fiscal year.
In the corresponding quarter of the previous year, the company's earnings report revealed a per-share loss of $0.24. This significant amount was attributed to the company's remarkable total revenue of $4.61 million generated during that specific period.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $-0.13 | +58.1% | 4.95 M | +5.3% |
| Q1 2024 | $-0.20 | +39.4% | 3.76 M | -8.9% |
| Q4 2023 | $-0.22 | +8.3% | 4.85 M | +36.5% |
| Q3 2023 | $-0.24 | +27.3% | 4.61 M | +38.4% |
| Q2 2023 | $-0.31 | -34.8% | 4.70 M | +35.7% |
| *Growth on year-over-year basis | ||||
EKSO has scheduled a conference call on 28th October 2024 at 04:30 PM eastern time to discuss the third quarter financial results and other related information.
Ekso Bionics Holdings (EKSO) experienced a trading range of $0.98 to $1.05, along with a total volume of 30.40 thousand shares during the day. The stock concluded Thursday's regular trading session at $1.02, indicating fall of 0.97 percent.
